4951 - 5000 of 9145 Results
Title
Year
- Application of longitudinal item response theory models to modeling Parkinson’s disease progression2022OPENTitle: Application of longitudinal item response theory models to modeling Parkinson’s disease progressionJournal Name: CPT: Pharmacometrics & Systems PharmacologyPublisher: WileyVol: 11Issue #: 10Start Page: 1382End Page: 1392Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/psp4.12853Best OA location URL: https://doi.org/10.1002/psp4.12853Citation Count: 10
-
OPENTitle: Earlier Dopaminergic Treatment in Parkinson's Disease Is Not Associated With Improved OutcomesJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 6Issue #: 3Start Page: 222End Page: 226Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12724Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12724Citation Count: 1
-
OPENTitle: Drug and Disease Effects in Parkinson's Psychosis: Revisiting the Role of DopamineJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 1Start Page: 32End Page: 36Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/mdc3.12851Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12851Citation Count: 22
-
OPENTitle: Bayesian Longitudinal Modeling of Early Stage Parkinson’s Disease Using DaTscan ImagesJournal Name: Lecture Notes in Computer SciencePublisher: Springer International PublishingVol:Issue #:Start Page: 405End Page: 416Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/978-3-030-20351-1_31Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10258684/pdf/nihms-1899421.pdfCitation Count: 4
-
OPENTitle: EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0Journal Name: European Journal of Nuclear Medicine and Molecular ImagingPublisher: Springer Science and Business Media LLCVol: 47Issue #: 8Start Page: 1885End Page: 1912Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00259-020-04817-8Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00259-020-04817-8.pdfCitation Count: 256
- Abstracts2020OPENTitle: AbstractsJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: S1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1002/mdc3.12905Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12905Citation Count: 4
-
OPENTitle: Reply To: Cerebral Vasomotor Reactivity in Parkinson's Disease: A Missing Link between Dysautonomia, White Matter Lesions, and Cognitive Decline?Journal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 8Start Page: 996End Page: 998Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13073Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13073Citation Count: 2
-
OPENTitle: Does MDS‐UPDRS Provide Greater Sensitivity to Mild Disease than UPDRS in De Novo Parkinson's Disease?Journal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 7Start Page: 1092End Page: 1099Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13329Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13329Citation Count: 16
- White Matter Hyperintensities Mediate Impact of Dysautonomia on Cognition in Parkinson's Disease2020OPENTitle: White Matter Hyperintensities Mediate Impact of Dysautonomia on Cognition in Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 6Start Page: 639End Page: 647Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13003Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13003Citation Count: 54
-
OPENTitle: Novel Approach to Movement Disorder Society–Unified Parkinson's Disease Rating Scale Monitoring in Clinical Trials: Longitudinal Item Response Theory ModelsJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 7Start Page: 1083End Page: 1091Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mdc3.13311Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13311Citation Count: 12
-
OPENTitle: Apathy and Anxiety in De Novo Parkinson's Disease Predict the Severity of Motor ComplicationsJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 1Start Page: 76End Page: 84Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13117Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7780944Citation Count: 23
-
OPENTitle: Association of Concurrent Olfactory Dysfunction and Probable Rapid Eye Movement Sleep Behavior Disorder with Early Parkinson's Disease ProgressionJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 9Issue #: 7Start Page: 909End Page: 919Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.13511Best OA location URL: https://doi.org/10.1002/mdc3.13511Citation Count: 6
- Abstracts2022OPENTitle: AbstractsJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 9Issue #: S1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13411Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13411Citation Count: 5
-
OPENTitle: Genetic Testing for GBA and LRRK2 Mutations: Is it Time for Routine Use?Journal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: S2Start Page: S26End Page: S31Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.13619Best OA location URL: https://doi.org/10.1002/mdc3.13619Citation Count: 2
- Quantified Striatal Dopaminergic Denervation as Predictor for Motor Outcomes in Parkinson's Disease2023OPENTitle: Quantified Striatal Dopaminergic Denervation as Predictor for Motor Outcomes in Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: 6Start Page: 896End Page: 902Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mdc3.13726Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13726Citation Count: 4
-
OPENTitle: Status of Current Biofluid Biomarkers in Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: S2Start Page: S18End Page: S20Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.13753Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13753Citation Count: 8
-
OPENTitle: Predictors of Future Deep Brain Stimulation Surgery in de novo Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: 6Start Page: 933End Page: 942Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mdc3.13747Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10272891/pdf/MDC3-10-933.pdfCitation Count: 7
-
OPENTitle: Targeting PERK signaling with the small molecule GSK2606414 prevents neurodegeneration in a model of Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 112Issue #:Start Page: 136End Page: 148Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2018.01.004Best OA location URL: https://repositorio.uchile.cl/handle/2250/167345Citation Count: 178
-
OPENTitle: Dynamics of Nigral Iron Accumulation in Parkinson's Disease: From Diagnosis to Late StageJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 8Start Page: 1654End Page: 1662Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.29062Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9810258Citation Count: 48
-
OPENTitle: Cortico-Subthalamic Field Potentials Support Classification of the Natural Gait Cycle in Parkinson’s Disease and Reveal Individualized Spectral SignaturesJournal Name: eneuroPublisher: Society for NeuroscienceVol: 9Issue #: 6Start Page: ENEURO.0325End Page: 22.2022Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1523/eneuro.0325-22.2022Best OA location URL: https://www.eneuro.org/content/eneuro/9/6/ENEURO.0325-22.2022.full.pdfCitation Count: 29
-
OPENTitle: The anti-dyskinetic effect of dopamine receptor blockade is enhanced in parkinsonian rats following dopamine neuron transplantationJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 62Issue #:Start Page: 233End Page: 240Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2013.09.021Best OA location URL: https://lup.lub.lu.se/record/4143204Citation Count: 19
- Freesurfer cortical normative data for adults using Desikan-Killiany-Tourville and ex vivo protocols2017OPENTitle: Freesurfer cortical normative data for adults using Desikan-Killiany-Tourville and ex vivo protocolsJournal Name: NeuroImagePublisher: Elsevier BVVol: 156Issue #:Start Page: 43End Page: 64Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuroimage.2017.04.035Best OA location URL: https://www.sciencedirect.com/science/article/am/pii/S1053811917303269?via%3DihubCitation Count: 53
- No evidence for toxicity after long-term photobiomodulation in normal non-human primates2017RESTRICTEDTitle: No evidence for toxicity after long-term photobiomodulation in normal non-human primatesJournal Name: Experimental Brain ResearchPublisher: Springer Science and Business Media LLCVol: 235Issue #: 10Start Page: 3081End Page: 3092Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00221-017-5048-7Citation Count: 41
-
OPENTitle: 0909 Pitolisant Pregnancy Registry: An Observational Study of the Safety of Pitolisant Exposure in Pregnant Women and Their OffspringJournal Name: SLEEPPublisher: Oxford University Press (OUP)Vol: 46Issue #: Supplement_1Start Page: A400End Page: A401Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/sleep/zsad077.0909Best OA location URL: https://academic.oup.com/sleep/article-pdf/46/Supplement_1/A400/50468109/zsad077.0909.pdfCitation Count: 1
- The BioFIND Study (Fox Investigation For New Discovery Of Biomarkers In Parkinson’s Disease): Design And Methodology (P4.043)2014RESTRICTEDTitle: The BioFIND Study (Fox Investigation For New Discovery Of Biomarkers In Parkinson’s Disease): Design And Methodology (P4.043)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 82Issue #: 10_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.82.10_supplement.p4.043Citation Count: 5
- Addressing Mental Health Needs in Rural and Indigenous Communities: Serving People on Their Terms2025OPENTitle: Addressing Mental Health Needs in Rural and Indigenous Communities: Serving People on Their TermsJournal Name: FocusPublisher: American Psychiatric Association PublishingVol: 23Issue #: 1Start Page: 19End Page: 24Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1176/appi.focus.20240035Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC11701816/Citation Count: 2
-
OPENTitle: Comparison of Patient and Expert Perceptions of the Attainment of Research Milestones in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 1Start Page: 171End Page: 177Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/mds.28319Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28319Citation Count: 4
- From Parkinson's Progression Markers Initiative to Parkinson's Precision Medicine Initiative: Still PPMI2026RESTRICTEDTitle: From Parkinson's Progression Markers Initiative to Parkinson's Precision Medicine Initiative: Still PPMIJournal Name: Annals of NeurologyPublisher: WileyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.78242Citation Count: 0
-
OPENTitle: Morphometric analysis of hypothalamic cells showing c-Fos proteins after movement restriction and EHF-irradiationJournal Name: PathophysiologyPublisher: Elsevier BVVol: 15Issue #: 1Start Page: 19End Page: 24Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.pathophys.2007.11.001Best OA location URL: https://doi.org/10.1016/j.pathophys.2007.11.001Citation Count: 7
- Funding of Parkinson research from industry and US federal and foundation sources2009RESTRICTEDTitle: Funding of Parkinson research from industry and US federal and foundation sourcesJournal Name: Movement DisordersPublisher: WileyVol: 24Issue #: 5Start Page: 731End Page: 737Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.22446Citation Count: 6
- Association of LRRK2 p.A419V with Parkinson’s Disease in East Asians and analysis of age at onset2026OPENTitle: Association of LRRK2 p.A419V with Parkinson’s Disease in East Asians and analysis of age at onsetJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page: 51End Page: 51Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-026-01265-3Best OA location URL: https://www.nature.com/articles/s41531-026-01265-3_reference.pdfCitation Count: 0
-
OPENTitle: Conversion of Quinazoline Modulators from Inhibitors to Activators of β-GlucocerebrosidaseJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 62Issue #: 3Start Page: 1218End Page: 1230Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acs.jmedchem.8b01294Best OA location URL: https://doi.org/10.7270/q280562cCitation Count: 26
-
OPENTitle: Chemical characterization of pro-inflammatory amyloid-beta peptides in human atherosclerotic lesions and plateletsJournal Name: Biochimica et Biophysica Acta (BBA) - Molecular Basis of DiseasePublisher: Elsevier BVVol: 1812Issue #: 11Start Page: 1508End Page: 1514Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bbadis.2011.07.004Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3185199Citation Count: 61
- Longitudinal evolution of non-motor symptoms according to age at onset in early Parkinson's disease2020RESTRICTEDTitle: Longitudinal evolution of non-motor symptoms according to age at onset in early Parkinson's diseaseJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 418Issue #:Start Page: 117157End Page: 117157Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2020.117157Citation Count: 22
-
OPENTitle: Practical approaches to inclusive recruitment practices in Parkinson's disease researchJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 16Issue #: 4Start Page: 709End Page: 722Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1177/1877718x261440708Best OA location URL: https://doi.org/10.1177/1877718x261440708Citation Count: 0
-
OPENTitle: Collaborative action for biomarker breakthroughs: Validating α-synuclein seed amplification assays in Parkinson's diseaseJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol:Issue #:Start Page: 1877718X261431949End Page: 1877718X261431949Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/1877718x261431949Best OA location URL: https://doi.org/10.1177/1877718x261431949Citation Count: 0
- α-synuclein seed amplification in Parkinson's disease – Authors' reply2023OPENTitle: α-synuclein seed amplification in Parkinson's disease – Authors' replyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 22Issue #: 11Start Page: 985End Page: 986Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(23)00371-xCitation Count: 7
-
OPENTitle: Autonomic dysfunction is associated with neuropsychological impairment in Lewy body diseaseJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 267Issue #: 7Start Page: 1941End Page: 1951Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00415-020-09783-7Best OA location URL: http://hdl.handle.net/10810/65454Citation Count: 29
- Intracellular Target-Specific Accretion of Cell Penetrating Peptides and Bioportides: Ultrastructural and Biological Correlates2015RESTRICTEDTitle: Intracellular Target-Specific Accretion of Cell Penetrating Peptides and Bioportides: Ultrastructural and Biological CorrelatesJournal Name: Bioconjugate ChemistryPublisher: American Chemical Society (ACS)Vol: 27Issue #: 1Start Page: 121End Page: 129Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acs.bioconjchem.5b00529Citation Count: 18
-
RESTRICTEDTitle: Association of Parkinson disease age of onset with DRD2, DRD3 and GRIN2B polymorphismsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 22Issue #:Start Page: 102End Page: 105Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2015.11.016Best OA location URL: http://doi.org/10.1016/j.parkreldis.2015.11.016Citation Count: 21
-
OPENTitle: Common and rare variants in HFE are not associated with Parkinson's disease in EuropeansJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 107Issue #:Start Page: 174End Page: 177Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2021.05.019Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8595489Citation Count: 3
- Constructing treatment episodes from concomitant medication logs: a prospective observational study2020OPENTitle: Constructing treatment episodes from concomitant medication logs: a prospective observational studyJournal Name: BMJ OpenPublisher: BMJVol: 10Issue #: 3Start Page: e034305End Page: e034305Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1136/bmjopen-2019-034305Best OA location URL: https://bmjopen.bmj.com/content/bmjopen/10/3/e034305.full.pdfCitation Count: 4
-
OPENTitle: Identification of small molecule dimethyoxyphenyl piperazine inhibitors of alpha-synuclein fibril growthJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page: 33108End Page: 33108Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41598-025-17658-yBest OA location URL: https://www.nature.com/articles/s41598-025-17658-y.pdfCitation Count: 0
-
OPENTitle: VGLUT2 in Parkinson’s disease: an emerging therapeutic targetJournal Name: Expert Opinion on Therapeutic TargetsPublisher: Informa UK LimitedVol: 30Issue #: 2Start Page: 103End Page: 107Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1080/14728222.2026.2619754Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC12853294/Citation Count: 0
- Profiling the Braak progression in Parkinson’s disease: a transcriptomics and ML driven identification of progressive biomarker and prognostic ceRNA signature2025RESTRICTEDTitle: Profiling the Braak progression in Parkinson’s disease: a transcriptomics and ML driven identification of progressive biomarker and prognostic ceRNA signatureJournal Name: NeurosciencePublisher: Elsevier BVVol: 593Issue #:Start Page: 41End Page: 55Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2025.12.011Citation Count: 3
-
OPENTitle: Dysregulated dopamine storage increases the vulnerability to α-synuclein in nigral neuronsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 47Issue #: 3Start Page: 367End Page: 377Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2012.05.012Best OA location URL: https://zenodo.org/record/3420973Citation Count: 57
-
RESTRICTEDTitle: Multiple system atrophy and apolipoprotein EJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 4Start Page: 647End Page: 650Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27297Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5889322Citation Count: 23
-
OPENTitle: Validating new symptom emergence as a patient-centric outcome measure for PD clinical trialsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 128Issue #:Start Page: 107118End Page: 107118Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.107118Best OA location URL: https://www.prd-journal.com/article/S1353-8020(24)01130-1/pdfCitation Count: 0
-
OPENTitle: Cryogel microcarriers for sustained local delivery of growth factors to the brainJournal Name: Journal of Controlled ReleasePublisher: Elsevier BVVol: 369Issue #:Start Page: 404End Page: 419Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.jconrel.2024.03.023Best OA location URL: https://ars.els-cdn.com/content/image/1-s2.0-S0168365924001755-ga1_lrg.jpgCitation Count: 14
-
OPENTitle: Quantifying Spatiotemporal Gait Parameters with HoloLens in Healthy Adults and People with Parkinson’s Disease: Test-Retest Reliability, Concurrent Validity, and Face ValidityJournal Name: SensorsPublisher: MDPI AGVol: 20Issue #: 11Start Page: 3216End Page: 3216Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/s20113216Best OA location URL: https://www.mdpi.com/1424-8220/20/11/3216/pdf?version=1591769863Citation Count: 49
